Freestone Grove Partners’s Collegium Pharmaceutical COLL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,761	Closed	-$232K	–	704
2025 Q1	$232K	Sell	7,761 -3,380	-30%	-$101K	﹤0.01%	513
2024 Q4	$319K	Buy	+11,141	New	+$319K	﹤0.01%	456